BioWorld

Sep. 22, 2006

View Archived Issues

Merck KGaA Buying Serono, Giving CHF16.6B Valuation

Merck KGaA agreed to acquire a controlling stake in Serono SA by purchasing the Bertarelli family's shares in the company, which represent 64.5 percent of its equity and 75.5 percent of its voting rights. (BioWorld Today) Read More

Phase II Alzheimer's Results Boost Shares Of Medivation

Read More

Alzheimer's, Like Prion Disease, 'Seeded' By Misshapen Proteins

Read More

Alexion Seeks FDA Approval For Soliris In PNH Indication

Read More

Axcan Drops ITAX In Functional Dyspepsia After Phase III Failure

Read More

Biogen Joins With Alnylam On RNAi Therapies For PML

Read More

Clinic Roundup

Read More

Appointments And Advancements

Read More

Other News To Note

Read More